A Cohort Dose-Escalation Phase 1 Study of Intramuscular Injection of Uricase-PEG 20

Trial Profile

A Cohort Dose-Escalation Phase 1 Study of Intramuscular Injection of Uricase-PEG 20

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Pegadricase (Primary)
  • Indications Gout; Hyperuricaemia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 08 Aug 2014 Status changed from recruiting to completed, according to a 3SBio media release.
    • 24 Feb 2010 New trial record.
    • 23 Feb 2010 Results are expected later in 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top